![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication March 2, 2006.
Revised April 18, 2006.
Accepted for publication April 24, 2006.
Matrix Metalloproteinases (MMPs) and their endogenous inhibitors, TIMPs, are produced in the gastrointestinal tract by several structural cells. The balance between MMPs and TIMPs is essential for many physiological processes in the gut. However, imbalance between MMPs and TIMPs plays an important role in the pathophysiology of diverse intestinal inflammatory conditions. We review the role of the MMP/TIMP system the pathogenesis of intestinal inflammatory diseases and pharmacologic perspectives for the use of compounds that restore the MMP/TIMP balance.
Key words:
Colitis, Crohn's disease, Inflammatory bowel disease, Matrix metalloproteinases, TIMP, Ulceraive Colitis
This article has been cited by other articles:
![]() |
K. Ishida, S. Takai, M. Murano, T. Nishikawa, T. Inoue, N. Murano, N. Inoue, D. Jin, E. Umegaki, K. Higuchi, et al. Role of Chymase-Dependent Matrix Metalloproteinase-9 Activation in Mice with Dextran Sodium Sulfate-Induced Colitis J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 422 - 426. [Abstract] [Full Text] [PDF] |
||||